Key Record Dates Identifier: NCT03267940
Brief Title: Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab, CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma

First Submitted : July 25, 2017
First Submitted that Met QC Criteria : August 28, 2017
First Posted : August 31, 2017

Last Update Submitted that Met QC Criteria : December 3, 2018
Last Update Posted : December 5, 2018